Your browser doesn't support javascript.
loading
EphB4 mediates resistance to antiangiogenic therapy in experimental glioma.
Uhl, Christian; Markel, Moritz; Broggini, Thomas; Nieminen, Melina; Kremenetskaia, Irina; Vajkoczy, Peter; Czabanka, Marcus.
Afiliação
  • Uhl C; Department of Neurosurgery, Universitätsmedizin Charite - Campus Mitte, Luisenstrasse 46, 10117, Berlin, Germany.
  • Markel M; Department of Neurosurgery, Universitätsmedizin Charite - Campus Mitte, Luisenstrasse 46, 10117, Berlin, Germany.
  • Broggini T; Department of Neurosurgery, Universitätsmedizin Charite - Campus Mitte, Luisenstrasse 46, 10117, Berlin, Germany.
  • Nieminen M; Department of Neurosurgery, Universitätsmedizin Charite - Campus Mitte, Luisenstrasse 46, 10117, Berlin, Germany.
  • Kremenetskaia I; Department of Neurosurgery, Universitätsmedizin Charite - Campus Mitte, Luisenstrasse 46, 10117, Berlin, Germany.
  • Vajkoczy P; Department of Neurosurgery, Universitätsmedizin Charite - Campus Mitte, Luisenstrasse 46, 10117, Berlin, Germany. peter.vajkoczy@charite.de.
  • Czabanka M; Department of Neurosurgery, Universitätsmedizin Charite - Campus Mitte, Luisenstrasse 46, 10117, Berlin, Germany. marcus.czabanka@charite.de.
Angiogenesis ; 21(4): 873-881, 2018 11.
Article em En | MEDLINE | ID: mdl-29987450

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Resistencia a Medicamentos Antineoplásicos / Inibidores da Angiogênese / Receptor EphB4 / Neoplasias Experimentais / Neovascularização Patológica Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Resistencia a Medicamentos Antineoplásicos / Inibidores da Angiogênese / Receptor EphB4 / Neoplasias Experimentais / Neovascularização Patológica Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article